Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma.

@article{Schmier2012MedicalSE,
  title={Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma.},
  author={Jordana Kate Schmier and David W Covert and Edmund C. Lau},
  journal={Clinical drug investigation},
  year={2012},
  volume={32 12},
  pages={835-42}
}
BACKGROUND Topical β-blockers are commonly prescribed for primary open-angle glaucoma. Existing research is limited regarding respiratory or cardiovascular events that may result from using these topical β-blockers. OBJECTIVE To evaluate inpatient and outpatient service encounters and payments associated with the topical adjunctive use of the β-blocker timolol for glaucoma. STUDY DESIGN Retrospective data analysis using 2004-2011 IMS Lifelink Health Plan Claims Database. PATIENTS… CONTINUE READING

From This Paper

Topics from this paper.
2 Citations
0 References
Similar Papers